. the software identified and measured a marker of svd and then gave a score indicating how severe the disease was ranging from mild to severe.
. may 16, 2018
.
boston cio of the year® orbie® awards
.
please enter a valid email address
.
.
.
while all of the drugs work on cgrp, they don�t all work the same way. three of them target the cgrp molecule itself. aimovig goes after cgrp's receptor in the brain.
.
if you would like to add a comment, please register or log in
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
.